
Mizza 250mg Injection
Marketer
Stenhill Labs
Salt Composition
Amikacin (250mg)
Overview Mizza 250mg Injection
Cefazolin 250mg Injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (such as pneumonia), brain, and bloodstream infections. Prophylactic use is also indicated in hospitalized individuals. Its mechanism involves bacterial growth inhibition. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional only, it requires adherence to the prescribed dosage schedule. Complete the entire course, even with symptom improvement, to prevent relapse or infection exacerbation. Typical side effects include injection site irritation and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Close monitoring, including kidney function, hearing, and urinalysis, may be necessary. Pregnancy is a contraindication; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Mizza 250mg Injection
Infections caused by bacteria
Major Benefits of Mizza 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mizza 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mizza 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Mizza 250mg Injection works:
The antibiotic injection, Mizza 250mg, inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Mizza 250mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Mizza 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administering Mizza 250mg Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
The administration of Mizza 250mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Mizza 250mg Injection requires careful consideration. Dosage modification of Mizza 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mizza 250mg Injection in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Mizza 250mg Injection :
Should you forget a scheduled dose of Mizza 250mg Injection, seek advice from your physician.
Facts to Know About Mizza 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Therapy | Anti-Infective Agents |
| Actions | Aminoglycoside antibiotics |
